ITMCTR2200006857尚未招募1 期
rology
Fangcun Hospital, Guangdong Provincial Hospital of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 50 至 80(—)
- 性别
- Male
入选标准
- •1. Male aged 60-80 years old 2. The diagnosis conforms to the diagnostic criteria of western medicine and traditional Chinese medicine for benign prostatic hyperplasia, and urodynamics indicates that detrusor contractility is weak or no contraction (BCI < 100or Pdet@Qmax < 40cmH2O) 3.PSA, digital intestinal examination and imaging are not abnormal. Prostate cancer should be excluded by prostate puncture if there are abnormalities. 4. The patient agreed to participate in the trial and signed the informed consent form. 5. The American Society of Anesthesia score (ASA) was rated 1-3.
排除标准
- •1. At present, it has been or will be included in other trials 2. The contractile force of detrusor is normal. Suffering from stress urinary incontinence, need to be treated or use a urine pad; 4. Suffering from urethral stricture or bladder neck obstruction; 5. History of prostate and bladder surgery; 6. Suffering from progressive malignant tumor or chronic consumptive disease; 7. The patient was complicated with severe cardiopulmonary disease or severe mental disorder. Combined with active infection; 9. Severe coagulation dysfunction
研究者
相似试验
进行中(未招募)
1 期
.EUCTR2018-003565-33-FRCHU de Clermont-Ferrand120
进行中(未招募)
1 期
.EUCTR2016-001341-41-FRCHU de Clermont-Ferrand
进行中(未招募)
不适用
.EUCTR2014-001452-28-FRCHU de Clermont-Ferrand
进行中(未招募)
1 期
..EUCTR2018-004411-49-FRCHU de Clermont-Ferrand50
进行中(未招募)
不适用
oMedDRA version: 14.0Level: HLGTClassification code 10035227Term: Plasma cell neoplasmsSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2011-001143-70-ESBreno Moreno de Gusmao
